We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$20.7B
AUM Growth
-$166M
Cap. Flow
-$582M
Cap. Flow %
-2.82%
Top 10 Hldgs %
30.44%
Holding
2,896
New
52
Increased
415
Reduced
1,909
Closed
89

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$65.1M
2
AAPL icon
Apple
AAPL
+$58M
3
MSFT icon
Microsoft
MSFT
+$49.2M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$25.9M
5
AL
Air Lease Corp
AL
+$21.6M

Sector Composition

Rank Sector Weight
1 Technology 30.28%
2 Financials 13.29%
3 Healthcare 10.43%
4 Consumer Discretionary 10.39%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKE icon
1451
Buckle
BKE
$2.28B
$949K ﹤0.01%
17,767
-841
-5% -$46.9K
IE icon
1452
Ivanhoe Electric
IE
$1.67B
$948K ﹤0.01%
59,325
+8,252
+16% +$118K
ATRO icon
1453
Astronics
ATRO
$4.56B
$947K ﹤0.01%
20,958
LMAT icon
1454
LeMaitre Vascular
LMAT
$1.89B
$947K ﹤0.01%
11,679
-558
-5% -$48K
PRCT icon
1455
Procept Biorobotics
PRCT
$1.25B
$947K ﹤0.01%
30,100
-1,344
-4% -$44.6K
CC icon
1456
Chemours
CC
$2.38B
$947K ﹤0.01%
80,299
-9,892
-11% -$127K
PACS icon
1457
PACS Group
PACS
$7.03B
$946K ﹤0.01%
24,645
-1,545
-6% -$33.9K
ROG icon
1458
Rogers Corp
ROG
$2.52B
$944K ﹤0.01%
10,310
-976
-9% -$83.8K
MLYS icon
1459
Mineralys Therapeutics
MLYS
$2.27B
$944K ﹤0.01%
26,005
+3,296
+15% +$132K
NWBI icon
1460
Northwest Bancshares
NWBI
$2.33B
$942K ﹤0.01%
78,474
-4,066
-5% -$49.5K
UFPT icon
1461
UFP Technologies
UFPT
$2.52B
$941K ﹤0.01%
4,237
-240
-5% -$51.4K
VAC icon
1462
Marriott Vacations Worldwide
VAC
$4.23B
$938K ﹤0.01%
16,264
-13,766
-46% -$814K
MQ icon
1463
Marqeta
MQ
$1.72B
$938K ﹤0.01%
49,380
-6,209
-11% -$119K
HRMY icon
1464
Harmony Biosciences
HRMY
$2.22B
$938K ﹤0.01%
25,068
-1,290
-5% -$42.4K
VSH icon
1465
Vishay Intertechnology
VSH
$5.27B
$938K ﹤0.01%
64,725
-3,562
-5% -$54K
FLYW icon
1466
Flywire
FLYW
$2.23B
$935K ﹤0.01%
66,004
-6,892
-9% -$94.3K
PSKY
1467
Paramount Skydance Corp
PSKY
$11.4B
$930K ﹤0.01%
69,413
-2,041
-3% -$31.9K
TRIP icon
1468
TripAdvisor
TRIP
$1.29B
$930K ﹤0.01%
63,866
-5,671
-8% -$86.3K
LTC
1469
LTC Properties
LTC
$2.15B
$924K ﹤0.01%
26,865
-1,330
-5% -$46.9K
CHCO icon
1470
City Holding Co
CHCO
$2.09B
$923K ﹤0.01%
7,747
-429
-5% -$52.2K
BRSL
1471
Brightstar Lottery PLC
BRSL
$2.16B
$922K ﹤0.01%
59,537
-7,270
-11% -$118K
AFRM icon
1472
Affirm
AFRM
$26.3B
$921K ﹤0.01%
12,380
+351
+3% +$25.3K
NVMI
1473
Nova
NVMI
$13.5B
$920K ﹤0.01%
2,759
BCRX icon
1474
BioCryst Pharmaceuticals
BCRX
$2.47B
$919K ﹤0.01%
117,853
-102
-0.1% -$737
CASH icon
1475
Pathward Financial
CASH
$1.8B
$916K ﹤0.01%
12,905
-1,105
-8% -$79.2K

Similar funds

MetLife Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, MetLife Investment Management held 2,896 positions worth $20.7B, down 0.8% from $20.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 4.9%. MetLife Investment Management opened 52 new positions and exited 89, leaving the 2,896-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2025 buy was RTX Corp: 321,368 shares worth $58.9M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $54.6M increase.
  • MetLife Investment Management's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $65.1M.
  • MetLife Investment Management fully exited Kellanova in Q4 2025, selling an estimated $5.48M.
  • MetLife Investment Management's ten largest holdings make up 30% of its $20.7B portfolio in Q4 2025.
  • MetLife Investment Management opened 52 new positions and closed 89 in Q4 2025.
  • MetLife Investment Management's portfolio value fell 0.8% quarter-over-quarter to $20.7B.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.